Independent journalist and contributor, Down To Earth. Her concerns relate to the way power structures in society - business corporations, governments and lobbies - impact the lives of the powerless.
WIPO’s piracy blacklist is flawed
Why is the UN body putting a stamp of approval on a system that is patently unjust and dangerous
CRISPR: A cutting-edge battle
The US has reopened the battle over CRISPR that has already seen several twists and turns in the past seven years
Why the US fears China
The trade war launched by Trump has the alleged theft of intellectual property at its core
Who cares about high drug prices?
Drug manufacturers have started charging high prices at levels unheard of earlier, but nobody is bothered
The new Patanjali of yoga
Did anyone think that Maharishi Patanjali, the giver of those priceless exercises, would become private property one day?
A strike for affordable medicines
Recently, the Delhi High Court allowed makers of generic medicines in India to export patented drugs to importing countries for regulatory approval
Tricky issue of policing the Internet
Instead of bans, regulations may be a better way of dealing with the downside of digital technology
New ruse in Big Pharma's old game
Drug multinationals are lobbying for a devious patent linkage system to block the entry of competitive generics
Monsanto's troublesome trait
Bayer is battling seed companies and farmers in several countries over royalty on Monsanto's GM seeds
US sound and fury over drug prices
The US Senate is outraged by the rapacious pricing policy of drug firms but will it act to reform the system?
Bedaquiline and India's patent law
Opposition to the new patent claims on the Johnson & Johnson drug is a test of how well the rules against evergreening are working
Software outsmarts drug research
Now, a programme can bypass patented drug pathways and create synthetically-produced medicines
No worries? Ask Simba
A furore over Disney's trademark on the Swahili phrase Hakuna Matata heats up the cultural appropriation debate
Patent Prosecution Highway: The fast track to disaster
India's decision to start one for Japanese firms could open the tollgates to hasty approvals
When judges copy
Should the rules on plagiarism matter as much as the independent analysis made by judges in adjudicating cases?
You can be sued for your social media posts
Copyright issues related to social media posts are a concern as platforms are shutting down accounts without notice
Beware of Japan's trade ambitions
Japan is pushing for higher levels of intellectual property protection that will cut access to affordable medicines
This is how rich nations protect profits of multinational pharma firms
When rich nations insist on patent linkage provisions in bilateral and regional trade pacts, there is a way out
The zero budget farming discord
There is unease over the crusader of natural farming, Subhash Palekar, for renaming the technique after himself
Can activism check Big Pharma’s profit motives?
As prices of life-saving drugs skyrocket, people from diverse fields are getting together to fight Big Pharma
US trading on thin ice
As Trump escalates the trade war with China, the key question is what constitutes theft of intellectual property
Fake science, shady journals
India is way behind in the patents it files, the reason being that much of its science is of dubious quality
Average 71 patents per drug!
Innovator companies are seeking hundreds of patents on a single drug to extend monopolies and increase prices
Outsourcing patent functions
WIPO begins talks on controversial proposal to allow countries to outsource their patent examination processes to another country
Clearing the smoke on packaging
WTO rules that Australian laws on tobacco packaging don't violate global obligations to protect intellectual property